Providing unrealistic hope on the potential success of covid-19 vaccines, whilst ignoring the challenges scientists are currently facing, can give your readers false certainty and contribute to the pandemic of misinformation.
One of the most important things for reporters to understand is what the various levels of clinical trials can and cannot offer - for example, that the Phase 1 trial does not reveal much about the effectiveness of vaccines - as well as being aware that press releases are not as factually useful as articles published in scientific journals.
Journalists also need to be transparent about the side effect that trial participants may experience, which may help reduce the social media backlash once people start complaining about how they feel after receiving the vaccine.
The article also advises reporters to mention the patient demographics used to test vaccines and to be honest about the challenges the new approaches present, especially because of the speed at which they are being developed.
Looking for a job in the media? Subscribe to our daily newsletter and keep an eye on our jobs board for the latest announcements.
Free daily newsletter
- John Crowley, freelance journalist, on working from home - or is it living at work?
- Death of student newspapers could thwart efforts to diversify the industry
- Top experts publish 250 recommendations for fighting the 'infodemic' on social platforms
- Tip: Ten common mistakes to avoid as a journalist
- Lucy Kueng, senior research associate at RISJ, on leading digital transformation in an age of disruption